New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2014
07:21 EDTINSYInsys Therapeutics to advance development of CBD to treat epilepsy
Insys Therapeutics announced plans to advance development of its pharmaceutical Cannabidiol, or CBD, a synthetically produced and over 99% pure form of cannabidiol, to treat epilepsy in children and adults. Insys has engaged a large international Clinical Research Organization to provide development and regulatory services and has hired Mark Davis as Senior Clinical Director to oversee this program. Insys plans to file an Investigational New Drug application with the FDA in the second half of 2014 for CBD for the treatment of epilepsy. In pediatrics, Insys plans to pursue development of treatments for Lennox-Gastaut Syndrome and Dravet Syndrome, which are orphan indications.
News For INSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
15:09 EDTINSYInsys falls after SIRF links drug to 'growing number' of deaths
Subscribe for More Information
April 23, 2015
07:17 EDTINSYInsys Therapeutics commences dosing in Phase 1/2 study of CBD oral solution
Subscribe for More Information
April 17, 2015
10:07 EDTINSYHigh option volume stocks
Subscribe for More Information
April 14, 2015
14:47 EDTINSYInsys Therapeutics management to meet with Jefferies
Meetings to be held in Denver/San Francisco on April 16-17 hosted by Jefferies.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use